Facilitating 3D Organ Printing with Plant-Based BioInks

There is a chronic shortage of organs available for transplant.  Bioprinted organs could dramatically increase accessibility to all patients in need of transplants.  Some simpler biofabricated ...


iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative

iBio to Support the 3D Bioprinting Industry with Enabling Biomaterials NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it is now part of a new ...


The Antibody Engineering & Therapeutics Summit

December 9-13, 2019
Marriott Marquis San Diego
San Diego, CA, USA


Why FastPharming ?

FastPharming overcomes issues presented by mammalian expression systems:

  • Speed: Avoids lengthy clone selection and MCB establishment processes by "transfecting at scale"
  • Scale-up: Simple & easy - just plant more plants
  • Sustainability:  Truly "green" manufacturing - no plastic waste when a plant is the "single-use bioreactor"
  • Safety:  Reduced risk of viral contamination
  • Quality:  Accessible, flexible glycosylation controls
  • Cost:  Lower facility CapEx and OpEx in many cases
Learn More

Increased Speed-to-Market

iBio CDMO Services

Process Development

FastPharming optimizes gene-expression, glycosylation, and purification parameters to deliver a robust process for your APIs.

cGMP Manufacturing

The FastPharming system transfects at large-scale to easily and reliably deliver biologics in clinical trial or commercial quantities.

Aseptic Fill/Finish

In-line labelling allows serialization of vials and bottles for greater quality assurance of mAbs, viral vectors, and other biologics.


An experienced analytical staff provides method development and validation support with expertise in protein characterization using mass spectrometry.

Quality & Regulatory

Quality systems have been carefully constructed to meet cGMP requirements, and iBio can provide regulatory guidance given the team’s experience with therapeutic development.

Factory Solutions

When the time is right, iBio facilitates insourcing by designing and building your own environmentally sustainable FastPharming facilities.

Technology Applications

The FastPharming platform produces a variety of recombinant products including:

  • Biobetter and biosimilar antibodies
  • Antigens for subunit vaccine design
  • Virus-like particles (VLP)
  • Lysosomal enzymes
  • Blood factors and cytokines
  • Scaffolds, maturogens and materials for 3D Bioprinting and biofabrication

Contact Us

Interested in applying the power of FastPharming to your project?

iBio offers the CDMO capabilities needed to develop and deliver biologics to market - process development, scale-up, cGMP manufacturing, bioanalytical product characterization, aseptic fill/finish, and quality and regulatory support.

Send us a Message